These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 9636565)

  • 1. Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.
    Wiesner RH
    Transplant Proc; 1998 Jun; 30(4):1399-400. PubMed ID: 9636565
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
    Arnold JC; Theilmann L
    Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with neoral cyclosporine through the oral route in liver transplantation.
    Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C
    Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoral is superior to FK 506 in liver transplantation.
    Levy GA
    Transplant Proc; 1998 Aug; 30(5):1812-5. PubMed ID: 9723293
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
    Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus in solid organ transplantation: an update.
    Shapiro R
    Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
    Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
    Transplant Proc; 1998 Jun; 30(4):1401-2. PubMed ID: 9636566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
    Mühlbacher F;
    Transplant Proc; 2001; 33(1-2):1339-40. PubMed ID: 11267317
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of immunosuppression on patient outcome after liver transplantation.
    Mueller AR; Platz KP; Willimski C; Berg T; Neuhaus R; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1495-6. PubMed ID: 9636608
    [No Abstract]   [Full Text] [Related]  

  • 11. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.
    Wiesner RH
    Transplantation; 1998 Aug; 66(4):493-9. PubMed ID: 9734494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus (FK506) is superior to cyclosporine in liver transplantation.
    Busuttil RW; Holt CD
    Transplant Proc; 1997; 29(1-2):534-8. PubMed ID: 9123119
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.
    Bismuth H
    Transplant Proc; 1995 Feb; 27(1):45-9. PubMed ID: 7533415
    [No Abstract]   [Full Text] [Related]  

  • 15. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
    Platz KP; Mueller AR; Neuhaus R; Keck HH; Lobeck H; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):2872-4. PubMed ID: 9365598
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
    Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J
    Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of the switch to tacrolimus in liver transplantation.
    González-Pinto I; Alonso O; Loinaz C; Gómez R; Rodríguez-Cañete A; Rodríguez F; Pérez-Saborido B; Paseiro G; Moreno-González E
    Transplant Proc; 1999 Sep; 31(6):2425-6. PubMed ID: 10500653
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the use of marginal liver grafts justified?
    Mueller AR; Platz KP; Krause P; Steinmüller T; Glanemann M; Neumann U; Lobeck H; Neuhaus P
    Transplant Proc; 1999; 31(1-2):401-2. PubMed ID: 10083160
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical use of FK 506 in liver transplantation.
    Klintmalm GB
    Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.